1. Home
  2. ERC vs AQST Comparison

ERC vs AQST Comparison

Compare ERC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERC
  • AQST
  • Stock Information
  • Founded
  • ERC 2003
  • AQST 2004
  • Country
  • ERC United States
  • AQST United States
  • Employees
  • ERC N/A
  • AQST N/A
  • Industry
  • ERC Finance/Investors Services
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • ERC Finance
  • AQST Health Care
  • Exchange
  • ERC Nasdaq
  • AQST Nasdaq
  • Market Cap
  • ERC 264.5M
  • AQST 272.9M
  • IPO Year
  • ERC N/A
  • AQST 2018
  • Fundamental
  • Price
  • ERC $9.39
  • AQST $4.07
  • Analyst Decision
  • ERC
  • AQST Strong Buy
  • Analyst Count
  • ERC 0
  • AQST 7
  • Target Price
  • ERC N/A
  • AQST $11.29
  • AVG Volume (30 Days)
  • ERC 64.4K
  • AQST 1.3M
  • Earning Date
  • ERC 01-01-0001
  • AQST 08-05-2025
  • Dividend Yield
  • ERC 8.37%
  • AQST N/A
  • EPS Growth
  • ERC N/A
  • AQST N/A
  • EPS
  • ERC 0.72
  • AQST N/A
  • Revenue
  • ERC N/A
  • AQST $54,228,000.00
  • Revenue This Year
  • ERC N/A
  • AQST N/A
  • Revenue Next Year
  • ERC N/A
  • AQST $45.71
  • P/E Ratio
  • ERC $12.92
  • AQST N/A
  • Revenue Growth
  • ERC N/A
  • AQST 5.29
  • 52 Week Low
  • ERC $8.51
  • AQST $2.12
  • 52 Week High
  • ERC $9.74
  • AQST $5.80
  • Technical
  • Relative Strength Index (RSI)
  • ERC 48.19
  • AQST 72.86
  • Support Level
  • ERC $9.44
  • AQST $3.62
  • Resistance Level
  • ERC $9.62
  • AQST $3.80
  • Average True Range (ATR)
  • ERC 0.08
  • AQST 0.19
  • MACD
  • ERC -0.00
  • AQST 0.05
  • Stochastic Oscillator
  • ERC 34.29
  • AQST 95.43

About ERC Allspring Multi-Sector Income Fund

Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: